Cullen Capital Management LLC increased its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 57.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 16,868 shares of the company’s stock after buying an additional 6,174 shares during the quarter. Cullen Capital Management LLC’s holdings in Clorox were worth $1,366,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the company. Pension & Wealth Management Advisors Inc. bought a new position in Clorox in the third quarter valued at approximately $26,000. Ancora Advisors LLC bought a new stake in shares of Clorox during the 2nd quarter worth $28,000. Avalon Trust Co bought a new stake in shares of Clorox during the 2nd quarter worth $29,000. Markowski Investments acquired a new stake in Clorox in the second quarter valued at about $30,000. Finally, Barrett & Company Inc. boosted its stake in Clorox by 86.0% in the third quarter. Barrett & Company Inc. now owns 372 shares of the company’s stock valued at $30,000 after buying an additional 172 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Clorox
Investors following CLX have been watching these stories:
- Positive Sentiment: Clorox Purell ProCare introduced new healthcare disinfecting wipes and a touch-free dispensing system at ISSA 2026. The launches broaden its healthcare product lineup, though their near-term financial impact was not specified. Article: Clorox Purell ProCare unveils healthcare innovations
- Neutral Sentiment: A separate article examines whether Wall Street is bullish or bearish on Clorox, but the supplied information does not include its conclusions. Article: Clorox Stock Outlook: Is Wall Street Bullish or Bearish?
- Negative Sentiment: Zacks Research lowered several forward EPS estimates, including FY2028 to $6.01 from $6.23, and reduced forecasts for multiple quarters. It also maintained a “Strong Sell” rating, adding to concerns about Clorox’s earnings outlook. The firm raised its Q1 2028 estimate, but the overall revisions were predominantly downward.
Insider Buying and Selling at Clorox
Clorox Price Performance
CLX stock opened at $106.62 on Wednesday. The company has a fifty day moving average price of $89.39 and a 200-day moving average price of $99.53. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a market capitalization of $12.92 billion, a P/E ratio of 17.66, a PEG ratio of 3.49 and a beta of 0.59. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.39 and a current ratio of 0.65.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. The company had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The firm’s revenue was up 33.3% compared to the same quarter last year. During the same period last year, the company earned $0.85 earnings per share. As a group, equities analysts expect that The Clorox Company will post 5.74 EPS for the current year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend was Wednesday, October 28th. Clorox’s dividend payout ratio is currently 89.93%.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on CLX shares. The Goldman Sachs Group reiterated a “sell” rating and issued a $74.00 target price on shares of Clorox in a research report on Tuesday, November 3rd. UBS Group set a $88.00 target price on shares of Clorox in a report on Tuesday, November 3rd. Evercore upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $99.00 price target on the stock in a research note on Monday, November 2nd. Wells Fargo & Company lifted their price target on shares of Clorox from $85.00 to $90.00 and gave the company an “equal weight” rating in a report on Tuesday, November 3rd. Finally, Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $125.00 to $98.00 in a research report on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $93.79.
Check Out Our Latest Analysis on CLX
Clorox Profile
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
See Also
- Five stocks we like better than Clorox
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
